DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Novartis (NYSE: NVS)

company name or ticker
Company Photos
(Click to zoom)

Novartis' Secukinumab Receives Favorable FDA Panel Vote - Analyst Blog

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

Why Biogen Idec Stock Shares Are Getting Pummeled Today

Biogen Idec shares tumbled more than 10% today on news that a Tecfidera patient was diagnosed with a rare brain disease.

Can Valeant's Strong Q3 Entice Allergan?

European ETFs Plunge As Trouble Hits Region's Core

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog

Novartis Presents Encouraging Data on Leukemia Candidate - Analyst Blog

Best European Stock Ideas Today

See More Articles...